ASCENDIS PHARMA - 043351P10
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | History | New | 1,900,000 | 244,872 | 4.23% | — | 1 | +1,900,000 | New | Q1 2021 | May 17, 2021 |